CRISPR Therapeutics AG (CRSP) Institutional Shareholders
CRISPR Therapeutics AG (CRSP) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $5.46B in CRSP holdings during the latest filing period.
Banque Cantonale Vaudoise is currently the largest disclosed institutional shareholder of CRSP tracked by InsiderSet, reporting ownership valued at approximately $1.31B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.36M, representing an estimated loss of -99.90% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed CRSP value among the investors covered in this analysis. Major shareholders include Banque Cantonale Vaudoise, ARK Invest, Blackrock, Inc., and several other long-term asset managers with concentrated positions in CRISPR Therapeutics AG (CRSP).
This page ranks the largest institutional CRSP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
505
Total Reported Value
$5.46B
Largest Holder
Banque Cantonale Vaudoise
Largest Position
$1.31B
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
53
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Banque Cantonale Vaudoise | 0.18% | 24,065 | $1,312,000,000 | $1,361,116 | -$1,310,638,884 | -99.90% | |
| ARK Invest | Cathie Wood | 3.35% | 9,460,939 | $515,999,631 | $535,110,710 | +$19,111,079 | +3.70% |
| Blackrock, Inc. | 0.01% | 8,348,977 | $455,353,197 | $472,218,139 | +$16,864,942 | +3.70% | |
| Orbis Allan Gray Ltd | 1.02% | 5,449,161 | $297,197,241 | $308,204,546 | +$11,007,305 | +3.70% | |
| Capital World Investors | 0.03% | 4,749,525 | $259,039,094 | $268,633,134 | +$9,594,040 | +3.70% | |
| State Street Corp | 0.01% | 4,321,666 | $235,703,664 | $244,433,429 | +$8,729,765 | +3.70% | |
| Gsk Plc | 29.17% | 3,220,627 | $175,652,997 | $182,158,663 | +$6,505,666 | +3.70% | |
| Geode Capital Management, Llc | 0.01% | 2,509,915 | $136,919,043 | $141,960,792 | +$5,041,749 | +3.68% | |
| T. Rowe Price Investment Management, Inc. | 0.07% | 2,053,017 | $111,972,000 | $116,118,642 | +$4,146,642 | +3.70% | |
| Sr One Capital Management, Lp | 10.70% | 2,038,763 | $111,194,134 | $115,312,435 | +$4,118,301 | +3.70% | |
| Two Sigma Investments, Lp | 0.08% | 1,988,621 | $108,459,389 | $112,476,404 | +$4,017,015 | +3.70% | |
| Fmr Llc | 0.00% | 1,908,503 | $104,089,735 | $107,944,930 | +$3,855,195 | +3.70% | |
| Sumitomo Mitsui Trust Group, Inc. | 0.05% | 1,720,734 | $93,848,832 | $97,324,715 | +$3,475,883 | +3.70% | |
| Amova Asset Management Americas, Inc. | 1.21% | 1,720,097 | $93,762,487 | $97,288,686 | +$3,526,199 | +3.76% | |
| Ecor1 Capital, Llc | 3.76% | 1,389,276 | $75,771,113 | $78,577,451 | +$2,806,338 | +3.70% | |
| Ubs Group Ag | 0.01% | 1,317,499 | $71,856,395 | $74,517,743 | +$2,661,348 | +3.70% | |
| Capital International Investors | 0.01% | 1,268,407 | $69,178,918 | $71,741,100 | +$2,562,182 | +3.70% | |
| Vanguard Capital Management Llc | 0.00% | 1,181,847 | $64,457,935 | $66,845,266 | +$2,387,331 | +3.70% | |
| Bank Of America Corp | 0.00% | 1,155,105 | $62,999,405 | $65,332,739 | +$2,333,334 | +3.70% | |
| Nea Management Company, Llc | 3.64% | 1,058,570 | $57,734,408 | $59,872,719 | +$2,138,311 | +3.70% | |
| Charles Schwab Investment Management Inc | 0.01% | 1,057,837 | $57,694,430 | $59,831,261 | +$2,136,831 | +3.70% | |
| D. E. Shaw & Co., Inc. | 0.03% | 893,812 | $48,748,506 | $50,554,007 | +$1,805,501 | +3.70% | |
| Morgan Stanley | 0.00% | 879,949 | $47,992,455 | $49,769,915 | +$1,777,460 | +3.70% | |
| Northern Trust Corp | 0.01% | 863,091 | $47,072,983 | $48,816,427 | +$1,743,444 | +3.70% | |
| Vanguard Portfolio Management Llc | 0.00% | 648,713 | $35,380,807 | $36,691,207 | +$1,310,400 | +3.70% | |
| Vanguard Fiduciary Trust Co | 0.01% | 570,040 | $31,089,982 | $32,241,462 | +$1,151,480 | +3.70% | |
| Citadel Advisors Llc | 0.01% | 465,796 | $25,404,514 | $26,345,422 | +$940,908 | +3.70% | |
| Jpmorgan Chase & Co | 0.00% | 431,669 | $24,569,275 | $24,415,199 | -$154,076 | -0.63% | |
| Susquehanna International Group, Llp | 0.02% | 427,178 | $23,298,288 | $24,161,188 | +$862,900 | +3.70% | |
| Millennium Management Llc | 0.01% | 382,032 | $20,836,025 | $21,607,730 | +$771,705 | +3.70% | |
| Iq Eq Fund Management (Ireland) Ltd | 1.33% | 381,991 | $20,833,789 | $21,605,411 | +$771,622 | +3.70% | |
| Bank Of New York Mellon Corp | 0.00% | 326,761 | $17,821,531 | $18,481,602 | +$660,071 | +3.70% | |
| Logos Global Management Lp | 0.70% | 300,000 | $16,362,000 | $16,968,000 | +$606,000 | +3.70% | |
| Squarepoint Ops Llc | 0.03% | 286,789 | $15,641,472 | $16,220,786 | +$579,314 | +3.70% | |
| Jump Financial, Llc | 0.14% | 277,952 | $15,159,502 | $15,720,965 | +$561,463 | +3.70% | |
| Dimensional Fund Advisors Lp | 0.00% | 275,375 | $15,034,803 | $15,575,210 | +$540,407 | +3.59% | |
| Goldman Sachs Group Inc | 0.00% | 272,372 | $14,855,182 | $15,405,360 | +$550,178 | +3.70% | |
| Norges Bank | 0.00% | 270,756 | $14,767,032 | $15,313,959 | +$546,927 | +3.70% | |
| Wells Fargo & Company/Mn | 0.00% | 263,169 | $14,353,246 | $14,884,839 | +$531,593 | +3.70% | |
| Ameriprise Financial Inc | 0.00% | 250,614 | $13,669,977 | $14,174,728 | +$504,751 | +3.69% | |
| Vestmark Advisory Solutions, Inc. | 0.12% | 242,266 | $13,213,188 | $13,702,565 | +$489,377 | +3.70% | |
| Raymond James Financial Inc | 0.00% | 231,988 | $12,652,626 | $13,121,241 | +$468,615 | +3.70% | |
| Nuveen, Llc | 0.00% | 203,089 | $11,076,474 | $11,486,714 | +$410,240 | +3.70% | |
| Royal Bank Of Canada | 0.00% | 173,045 | $9,438,000 | $9,787,425 | +$349,425 | +3.70% | |
| Marex Group Plc | 0.08% | 170,584 | $9,303,652 | $9,648,231 | +$344,579 | +3.70% | |
| Swiss National Bank | 0.00% | 169,200 | $9,228,168 | $9,569,952 | +$341,784 | +3.70% | |
| Susquehanna Portfolio Strategies, Llc | 0.14% | 164,026 | $8,945,978 | $9,277,311 | +$331,333 | +3.70% | |
| Legal & General Group Plc | 0.00% | 163,810 | $8,934,198 | $9,265,094 | +$330,896 | +3.70% | |
| Lpl Financial Llc | 0.00% | 153,581 | $8,376,280 | $8,686,541 | +$310,261 | +3.70% | |
| Versant Venture Management, Llc | 4.99% | 148,831 | $8,117,243 | $8,417,881 | +$300,638 | +3.70% |
Frequently asked questions about CRSP
Who owns the most CRSP stock?
The largest holders of CRSP are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CRISPR Therapeutics AG (CRSP).
Is CRSP widely held by superinvestors?
Many widely followed stocks like CRSP appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CRSP is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.